Skip to main content

Articles

Page 4 of 13

  1. The aim of the study was to investigate the common deficiencies observed in the Finished Pharmaceutical Product (FPP) section of generic product applications submitted to SAHPRA. The study was conducted retros...

    Authors: Lerato Moeti, Madira Litedu and Jacques Joubert
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:6
  2. Vaccines have become the best weapon for epidemic prevention and control in the absence of standard approved effective therapies. However, skepticism about the vaccine efficacy and safety is constantly reporte...

    Authors: Philippe Hanna, Aline Issa, Ziad Noujeim, Mira Hleyhel and Nadine Saleh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:5
  3. During the early phase of the COVID-19 pandemic, antibiotic usage among COVID-19 patients was noted to be high in many countries. The objective of this study was to determine the prevalence of antibiotic usage...

    Authors: Izzati-Nadhirah Mohamad, Calvin Ke-Wen Wong, Chii-Chii Chew, E-Li Leong, Biing-Horng Lee, Cheng-Keat Moh, Komalah Chenasammy, Steven Chee-Loon Lim and Hong-Bee Ker
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:4
  4. Substandard and Falsified (SF) medical products are a growing global concern. They harm the individual patient, the healthcare system and the economy. The World Health Organisation (WHO) has highlighted contri...

    Authors: R. J. Moshoeshoe, G. M. Enslin and D. R. Katerere
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:3
  5. Globally, an estimated 8.1 million children under 5 years die annually in developing countries. Ensuring essential medicines are accessible and affordable to the population is key to saving lives. This study i...

    Authors: Shannice Mahadeo, Keshmika Narain, Lungelo Mhlongo, Desmaine Chetty, Lindelani Masondo, Mandla Zungu, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:2
  6. Polypharmacy is the administration of an excessive number of medicines and a significant irrational medicine use practice. Little is known about this practice in South Africa. This study aimed to determine the...

    Authors: Adetola Olaniyi Bojuwoye, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:1
  7. During disasters or crises, the traditional models of supply chain encounter failure and skewedness under the inevitable and unknown pressures. The procurement and transformation of required equipment to the i...

    Authors: Peivand Bastani, Omid Sadeghkhani, Ramin Ravangard, Rita Rezaei, Parisa Bikine and Gholamhossein Mehralian
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:115
  8. Variations in practice are commonplace in healthcare where health professionals, such as pharmacists act as autonomous practitioners. This is evident in simulated patient studies, where pharmacists practice do...

    Authors: Deanna Mill, Jacinta L. Johnson, Kenneth Lee, Sandra M. Salter, Danielle D’Lima, Liza Seubert, Rhonda Clifford and Amy T. Page
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:114
  9. The proportion of days covered (PDC) is used to estimate medication adherence by looking at the proportion of days in which a person has access to the medication, over a given period of interest. This study ai...

    Authors: David Prieto-Merino, Amy Mulick, Craig Armstrong, Helen Hoult, Scott Fawcett, Lina Eliasson and Sarah Clifford
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:113
  10. The Commonwealth Pharmacists Association (CPA) is a charity representing pharmacists across the Commonwealth, with the vision of empowering and collaboratively develop the profession and fully utilise the pote...

    Authors: Ayesha Iqbal, Victoria Rutter, Gizem Gülpınar, Manjula Halai, Briella Awele, Rasha Abdelsalam Elshenawy, Claire Anderson, Rabia Hussain and Amy Hai Yan Chan
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:112
  11. Community pharmacists (CPs) are increasingly facing occupational challenges as a result of the COVID-19 pandemic, putting them at high risk of burnout. This study aimed to assess the prevalence of burnout amon...

    Authors: Dalal Youssef, Janet Youssef, Hamad Hassan and Linda Abou-Abbas
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:111
  12. While having access to safe and efficient vaccines is essential for eradicating the COVID-19 pandemic, gaining marketing authorisation is a critical step in enabling and speeding this process. On December 2, 2...

    Authors: Nasir Abbas and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:110
  13. Clinical pharmacists have an important role in inter-professional healthcare collaboration for epilepsy management. However, the pharmacy practices of managing epilepsy are still limited in Vietnam, deterring ...

    Authors: Hong Tham Pham, Minh-Hoang Tran, Ngoc Quy Nguyen, Van Tan Vo and Manh Hung Tran
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:109
  14. Access to maternal healthcare services is an essential pre-requisite for improving women’s health. However, due to poor access and underutilization, women in developing countries remain vulnerable to various c...

    Authors: Madeeha Malik, Katherine Prescott, Maliha Khalid, Ayisha Hashmi and Ayyaz Kiani
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:108
  15. Self-medication of medicines is a global issue particularly among those with good access and familiarity with medications such as university students. It has a significant impact on drug resistance and medicat...

    Authors: Getahun Fetensa, Tadesse Tolossa, Werku Etafa and Ginenus Fekadu
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:107
  16. There are limited studies on the role of efficient regulatory mechanisms in facilitating greater access to Hepatitis C virus (HCV) treatment. Evidence to support the importance of effective pharmaceutical poli...

    Authors: Mahmoud H. Teaima, Adi Al-Nuseirat, Dalia Abouhussein, Osama A. Badary and Mohamed A. El-Nabarawi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:106
  17. The standard treatment guidelines (STGs) and essential medicines list (EML) were a policy option recommended in the National Drug Policy for South Africa in 1996 to address the irrational and bloated medicines...

    Authors: Tashni Govender, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:105
  18. Alleviating acute and chronic pain is a moral imperative for health professionals and health systems, and it requires adequate access to and use of essential opioid analgesics. However, this is still a neglect...

    Authors: Serena Frau, Anselme Mubeneshayi Kananga, Jackie Ndona Kingolo, Ghislaine Mbelu Kanyunyu, André Katele H. Zongwe, Aaron Nshindi Tshilengi and Raffaella Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:104
  19. In Lebanon, the role of the pharmacist remains underestimated in the medication reconciliation process, especially in surgical departments. This study aims to assess the impact of pharmacist-conducted medicati...

    Authors: Ahmad El Ouweini, Lamis R. Karaoui, Nibal Chamoun, Chahine Assi, Kaissar Yammine and Elsy Ramia
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:103
  20. With the outbreak of Coronavirus infection (COVID-19), pharmacists play an important role in supporting local health during this emergency.

    Authors: Iman A. Basheti, Nizar M. Mhaidat, Sayer Al-Azzam, Rajaa Alqudah, Razan Nassar, Hamzah Alzubaidi, Mahmoud S. Abu-Samak and Eman Abu-Gharbieh
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:102
  21. The Department of Health and Human Services and the Food and Drug Administration released the Safe Importation Action Plan in July 2020 detailing methods to import medicines from Canada to combat increasing dr...

    Authors: John B. Hertig, Jade M. Jochem and Allissa M. Long
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:101
  22. Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and st...

    Authors: Kashif Hussain, Rahila Ikram, Gul Ambreen and Muhammad Sohail Salat
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:100
  23. Cancer patients are a complex and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are especially essential, since medication discrepancies can l...

    Authors: Ali Elbeddini, Anthony To, Yasamin Tayefehchamani and Cindy Xin Wen
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:98
  24. Private sector retail pharmacies, or drug shops, play an important role in access to essential medicines and services in low-and-middle-income countries. Recognising that they have the potential to contribute ...

    Authors: Geetanjali Lamba, Zubin Cyrus Shroff, Zaheer-Ud-Din Babar and Abdul Ghaffar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):94

    This article is part of a Supplement: Volume 14 Supplement 1

  25. Patent and proprietary medicine vendors (PPMVs) form part of the informal healthcare system and are the first point of call for 75% of Nigerians who live in rural and underserved areas where there is limited a...

    Authors: C. J. Uneke, I. Obeka, B. I. Uneke, A. Umeokonkwo, C. A. Nweze, K. I. Otubo and O. E. Uguru
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):92

    This article is part of a Supplement: Volume 14 Supplement 1

  26. Indonesia is the second country with the highest number of malaria cases in Southeast Asia. Private health providers including community pharmacies often become the first point of care for the population seeki...

    Authors: Astri Ferdiana, Utsamani Cintyamena, Luthfi Azizatunnisa’, Edi Sunandar and Ari Probandari
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):90

    This article is part of a Supplement: Volume 14 Supplement 1

  27. The role of community drug shops in providing primary care has been recognized as important in Myanmar as in other countries. The contribution by private community drug shops to National Tuberculosis case noti...

    Authors: May Me Thet, Myat Noe Thiri Khaing, Su Su Zin, Sandar Oo, Ye Kyaw Aung and Si Thu Thein
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):89

    This article is part of a Supplement: Volume 14 Supplement 1

  28. The low utilisation of modern contraceptives in many low- and middle-income countries remains a challenge. Patent medicine vendors (PMVs) that operate in the informal health sector, have the potential to addre...

    Authors: Mojisola Morenike Oluwasanu, Ayodeji Matthew Adebayo, Faizah Tosin Okunade, Olayinka Ajayi, Akinwumi Oyewole Akindele, John Stanback and Ademola Johnson Ajuwon
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):88

    This article is part of a Supplement: Volume 14 Supplement 1

  29. The Zambia Medicines Regulatory Authority (ZAMRA) piloted the implementation of Guidelines on Operating Health Shops in Zambia in 2016, with a view to making basic medicines more accessible to communities. The...

    Authors: Joseph M. Zulu, Doreen Sitali, Zubin Cyrus Shroff, Geetanjali Lamba, George Sichone, Charles Michelo, Chileshe H. Mpandamabula, Wesely Mwambazi, Cecilia Mwenda and Malizgani P. Chavula
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):87

    This article is part of a Supplement: Volume 14 Supplement 1

  30. The National Drug Policy in Bangladesh prohibits the sale and distribution of antibiotics without prescription from a registered physician. Compliance with this policy is poor; prescribing antibiotics by unqua...

    Authors: Fosiul Alam Nizame, Dewan Muhammad Shoaib, Emily K. Rousham, Salma Akter, Mohammad Aminul Islam, Afsana Alamgir Khan, Mahbubur Rahman and Leanne Unicomb
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):85

    This article is part of a Supplement: Volume 14 Supplement 1

  31. Anticoagulants are the cornerstone therapy for the management of venous thromboembolism (VTE) and atrial fibrillation (AF). Pharmacists should be confident and equipped with the skill and updated knowledge in ...

    Authors: Sze Ling Tan, Zai Yang Yong, Jerry Ee Siung Liew, Hadzliana Zainal and Sania Siddiqui
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:97
  32. The lack of access to safe medicines and quality healthcare services in peri-urban and rural areas is a major challenge driving a health system to innovate new models of care. This commentary will discuss the ...

    Authors: Nadia Bukhari, Maryam Siddique, Nazia Bilal, Sobia Javed, Arzu Moosvi and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:96
  33. Discussion of the necessity of the compulsory vaccination of UK patient-facing care workers as an employment conditionality has deflected from the initial and ongoing impact of Coronavirus disease on relativel...

    Authors: Richard Antony Powell, Shivali Lakhani, Marsha Alter, Steven Guan, Jehanita Jesuthasan and Dasha Nicholls
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:95
  34. Oncology drugs are frequently approved on the basis of surrogate outcomes that require further trials to confirm the benefits, but at times these trials fail and regulators need to decide whether to withdraw a...

    Authors: Joel Lexchin
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:93
  35. An urgent need for coronavirus infectious disease (COVID-19) treatment has resulted in off-label drug use. Although previous studies had investigated the adverse drug reaction (ADR) of the medications for COVI...

    Authors: Jia Yin Lee, Abby Shoon Yeun Ang, Nurdalila Mohd Ali, Li Min Ang and Azura Omar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:84
  36. Patient satisfaction is a widely used indicator to measure quality of pharmacy services. Currently, a transformational pharmacy service called auditable pharmaceutical transactions and services is being implem...

    Authors: Ayalew Adinew, Mamo Feyissa, Berhanu Tadesse, Birhanu Demeke, Tamrat Assefa, Mahdi Abdella, Edessa Diriba, Regasa Bayisa, Elias Geremew, Fikresilasie Alemu, Edmealem Ejigu, Tesfaye Seifu, Aschalew Nardos, Demelash Dejene, Mekete Mideksa and Natnael Solomon
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:83
  37. This study estimated the GDP share of pharmaceuticals in Iran based on the drivers of pharmaceutical expenditure and compared it with that of 31 members of the Organisation for Economic Cooperation and Develop...

    Authors: Azin Kadkhodamanesh, Vida Varahrami, Leila Zarei, Farzad Peiravian, Mohammad Hadidi and Nazila Yousefi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:82
  38. For more than a decade, direct oral anticoagulants (DOACs) have been approved in clinical practice for multiple indications such as stroke prevention in non-valvular atrial fibrillation treatment of deep vein ...

    Authors: Abdulrhman Alrowily, Zahraa Jalal, Mohammed H. Abutaleb, Nermin A. Osman, Maha Alammari and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:81
  39. Immunization supply chains (iSCs) move vaccines from manufacturer to point of use with the added complexities of requiring cold chain and an increasing need for agility and efficiency to ensure vaccine quality...

    Authors: Wendy Prosser, Cary Spisak, Benjamin Hatch, Joseph McCord, Marie Tien and Greg Roche
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:80
  40. The COVID-19 pandemic has disproportionately affected all essential healthcare services delivery in low-resource settings. This study aimed to explore the challenges and experiences of providers and users of c...

    Authors: Asmita Priyadarshini Khatiwada, Smriti Maskey, Nistha Shrestha, Sunil Shrestha, Saval Khanal, Bhuvan KC and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:79
  41. South Africa faces a heavy burden of disease, which impacts resource allocation. The needs of South Africa require efficient translation into pharmaceutical expenditure for medicine provision, to ensure availa...

    Authors: Lirosha Moodley, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:78
  42. Utilizing community pharmacists (CPs) as immunizers has being adopted in various countries as approach to boost influenza vaccination coverage. Our study aims to explore the Lebanese CPs’ willingness to admini...

    Authors: Dalal Youssef, Linda Abou-Abbas and Hamad Hassan
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:77
  43. Over-the-counter (OTC) medicines are typically safe. However, there is evidence that OTC medicines can sometimes cause harm as a result of their misuse, abuse and dependence.

    Authors: Mohammad Algarni, Muhammad Abdul Hadi, Asma Yahyouche, Sajid Mahmood and Zahraa Jalal
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:76
  44. The argument about funding criteria poses challenges for health decision-makers in all countries. This study aimed to investigate the public and decision-maker preferences for pharmaceutical subsidy decisions ...

    Authors: Gita Afsharmanesh, Farimah Rahimi, Leila Zarei, Farzad Peiravian and Gholamhossein Mehralian
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:74
  45. One in four people experience a mental health problem every year and improving mental health care is an international priority. In the course of their work, pharmacists frequently encounter people with mental ...

    Authors: H. C. Gorton, H. Macfarlane, R. Edwards, S. Farid, E. Garner, M. Mahroof, S. Rasul, D. Keating, H. Zaman, J. Scott, I. Maidment and J. Strawbridge
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:73
  46. Easy access to medicines provided by private medicine retailing facilities including that of over-the-counter medicine retailers, have gained prominence in sub-Saharan Africa. Although over-the-counter medicin...

    Authors: Benjamin Kwarteng Frempong, Anthony Amalba, Nina Donkor and Kwadwo Owusu Akuffo
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:72

Annual Journal Metrics